Celyad Oncology SA (CYAD)

US1512052002 - ADR

0.47  -0.06 (-11.1%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.005.00K6.00K3.12M
Cost Of Goods
0.000.000.000.000.00
Gross Profit
0.000.005.00K6.00K3.12M
Operating Expenses
5.77M26.39M16.98M28.89M41.10M
Research and Development
17.70M19.50M20.01M23.75M22.73M
Selling, General, and Administrative Expenses
10.34M9.66M8.99M8.72M10.12M
Operating Income
-5.77M-26.39M-16.98M-28.88M-37.99M
Interest Income/Expense
1.00K-206.00K-365.00K92.00K466.00K
Other Income/Expense
-14.00K95.00K148.00K147.00K95.00K
Non Recurring Items
-35.08M-1.00K-10.00KN/A0.00
Income Before Taxes
-40.87M-26.50M-17.20M-28.64M-37.43M
Income Tax
65.00K10.00K0.00-8.00K0.00
Net Income
-40.94M-26.51M-17.20M-28.63M-37.43M
EBITDA
-4.33M-24.87M-15.14M-27.09M-36.87M
 
Per Share Data
EPS Diluted Total Ops
-1.81-1.70-1.23-2.29-3.36
 
Statistics
Gross Profit Margin
N/AN/A100.00%100.00%100.00%
Profit Margin
N/AN/A-344080.00%-477200.00%-1201.51%
Operating Profit Margin
N/AN/A-339540.00%-481316.67%-1219.52%

All data in EUR

Charts